Dr. Leach is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Aliina Health Cancer Institute
800 E. 28th Street
Minneapolis, MN 55407Phone+1 612-863-0200
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1997 - 1998
- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1995 - 1996
- University of Oklahoma Health Sciences CenterResidency, Ophthalmology, 1994 - 1995
- University of Oklahoma Health Sciences CenterInternship, Internal Medicine, 1993 - 1994
- University of Minnesota Medical SchoolClass of 1993
Certifications & Licensure
- MN State Medical License 1999 - 2025
- WI State Medical License 1999 - 2001
- OK State Medical License 1994 - 1999
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Start of enrollment: 2009 Nov 17
- Join now to see all
Publications & Presentations
PubMed
- 46 citationsA Prospective Cohort Study of Patients With Peripheral T-Cell Lymphoma in the United StatesKenneth R. Carson, Steven M. Horwitz, Lauren C. Pinter-Brown, Steven T. Rosen, Barbara Pro
Cancer. 2017-04-01 - 3355 citationsAtezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello
Lancet. 2017-01-21 - 32 citationsTargeted eHealth Intervention to Reduce Breast Cancer Survivors' Fear of Recurrence: Results from the FoRtitude Randomized Trial.Lynne I. Wagner, Janet A. Tooze, Daniel L. Hall, Beverly J. Levine, Jennifer L. Beaumont
Journal of the National Cancer Institute. 2021-05-31
Press Mentions
- Prime Therapeutics Welcomes Joseph Leach, M.D. As Chief Medical OfficerApril 8th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: